Development of a Candida glabrata dominant nutritional transformation marker utilizing the Aspergillus nidulans acetamidase gene (amdS)

Jianmin Fu, Morganne Blaylock, Cameron F. Wickes, William Welte, Adrian Mehrtash, Nathan Wiederhold, Brian L. Wickes

Research output: Contribution to journalArticle

2 Scopus citations


The gene encoding Aspergillus nidulans acetamidase (amdS) was placed under control of Candida albicans ACT1 promoter and terminator sequences and then cloned into a plasmid containing C. glabrata ARS10, CEN8 or ARS10+CEN8 sequences. All plasmids transformed C. glabrata wild-type cells to acetamide+, with the ARS-only containing plasmid transforming cells at the highest frequencies (>1.0 × 104 transformants μg-1). Plasmids were rapidly lost under non-selective conditions with the frequency dependent on chromosomal element, thus recycling the acetamide- phenotype. The amdS plasmid was used to transform a set of clinical isolates resistant to a variety of antifungal drugs. All strains were successfully transformed to the acetamide+ phenotype at high frequency, confirming that this plasmid construct could be used as a simple dominant marker on virtually any strain. Gap repair experiments demonstrated that just as in Saccharomyces cerevisiae, gap repair functions efficiently in C. glabrata, suggesting that C. glabrata has numerous similarities to S. cerevisiae with regard to ease of molecular manipulation. The amdS system is inexpensive and efficient, and combined with existing C. glabrata plasmid elements, confers a high transformation frequency for C. glabrata with a phenotype that can be easily recycled.

Original languageEnglish (US)
Article numberfow023
JournalFEMS Yeast Research
Issue number3
StatePublished - May 1 2016



  • ARS
  • Acetamide
  • Antifungal
  • CEN

ASJC Scopus subject areas

  • Microbiology
  • Applied Microbiology and Biotechnology

Cite this